Norristown, PA, United States of America

Nicolas D Kirkland

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Xwpharma Ltd.. Active years: 2022-2025.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Nicolas D. Kirkland

Introduction

Nicolas D. Kirkland is a notable inventor based in Norristown, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release granulations. With a total of 2 patents, his work has the potential to impact the way active pharmaceutical ingredients are delivered in oral compositions.

Latest Patents

Kirkland's latest patents focus on pharmaceutical granulations that feature a functional coating surrounding a core containing a water-soluble active pharmaceutical ingredient. This innovative coating allows for either immediate release or controlled release of the active ingredient. Such advancements can enhance the effectiveness of oral pharmaceutical compositions, providing better therapeutic outcomes for patients.

Career Highlights

Throughout his career, Kirkland has demonstrated a commitment to advancing pharmaceutical technology. His work at Xwpharma Ltd. has positioned him as a key player in the industry, where he continues to explore new methodologies for drug delivery systems.

Collaborations

Kirkland has collaborated with talented individuals such as Sami Karaborni and Daniel M. Canafax. These partnerships have fostered an environment of innovation and creativity, further enhancing the development of groundbreaking pharmaceutical solutions.

Conclusion

Nicolas D. Kirkland's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in drug delivery systems, ultimately benefiting patients and healthcare providers alike.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…